4
Rancés AC y cols. Abordaje mininvasivo de la acalasia en estadio final . Rev Argent Cir. 2025;117(1):1-6  
mininvasiva para el tratamiento de la acalasia en estadio  
No obstante, se deberá esperar el resultado  
final resultó la técnica más empleada, con bajo porcentaje de más estudios para determinar cuál es la opción más  
de complicaciones. Otras técnicas también fueron usadas adecuada que demuestre seguridad y eficacia a largo  
para otros casos seleccionados en forma mulꢀdisciplinaria. plazo.  
■
ENGLISH VERSION  
Introducꢀon  
using manometry, upper gastrointesꢀnal endoscopy,  
and imaging tests such as upper gastrointesꢀnal series  
End-stage achalasia is characterized by severe and, in some paꢀents, computed tomography. (Figs. 1  
dilaꢀon and tortuosity of the esophagus. The classic and 2).  
clinical presentaꢀon includes dysphagia, progressive  
malnutriꢀon and there is usually a history of failed  
1
,2  
surgical myotomy . The aim of this presentaꢀon is to  
describe a case series of megaesophagus due to end-  
stage achalasia that was managed with surgery at our  
insꢀtuꢀon.  
■ FIGURE 1  
Material and methods  
We conducted an observaꢀonal, retrospecꢀve  
and descripꢀve study. All the paꢀents with end-stage  
achalasia operated on using a minimally invasive  
approach between March 2008 and October 2023 were  
included in the study.  
The data analyzed, obtained from a prospecꢀve  
database, included the demographic characterisꢀcs,  
clinical presentaꢀon, surgical techniques and  
postoperaꢀve complicaꢀons.  
The treatment for each individual case was  
determined by a mulꢀdisciplinary team involving the  
department of surgery, the gastrointesꢀnal moꢀlity  
laboratory and the nutriꢀonal support team.  
Categorical variables were expressed as  
number or percentage and conꢀnuous variables as  
mean and standard deviaꢀon.  
Upper gastrointesꢀnal series showing megaesophagus with tortuo-  
siꢀes  
The study protocol was approved by the  
Teaching and Research Commiꢁee of our insꢀtuꢀon.  
■ FIGURE 2  
Results  
A total of 8 paꢀents were operated on during  
the study period; mean age was 56 ± 11.2 years, and 5  
were female.  
One case corresponded to megaesophagus  
due to Chagas disease and the other 7 were due to  
recurrence of symptoms aꢂer a Heller-Dor myotomy  
that had been managed with endoscopic dilaꢀons.  
All paꢀents presented dysphagia, 5 reported  
weight loss and one paꢀent presented malnutriꢀon  
and required nutriꢀonal support prior to surgery. Three  
paꢀents presented regurgitaꢀon and only one paꢀent  
complaint of chest pain. In all cases, evaluaꢀon was  
performed in the gastrointesꢀnal moꢀlity laboratory  
Computed tomography scan of the thorax with oral contrast showing  
esophageal dilaꢀon due to end-stage achalasia.  
Rancés AC y cols. Abordaje mininvasivo de la acalasia en estadio final . Rev Argent Cir. 2025;117(1):1-6  
5
Two paꢀents underwent minimally invasive reflux with an acceptable response to proton pump  
esophagectomy, one with the laparoscopic transhiatal inhibitors and prokineꢀcs. The paꢀent with Roux-  
a fistula that required  
approach, and the other with the three-stage procedure en-Y bypass developed  
in prone posiꢀon (Fig. 3). Five paꢀents underwent reintervenꢀons for flushing and drainage. Two paꢀents  
hand-sewn cardioplasty, as described in Figure 4, and were lost to follow-up: one who underwent transhiatal  
one paꢀent required resecꢀon of the esophagogastric esophagectomy and another who underwent  
juncꢀon with Roux-en-Y reconstrucꢀon.  
cardioplasty. In the remaining cases which conꢀnued  
Postoperaꢀve complicaꢀons included one case to be monitored, there was significant relief of  
of pneumonia in a paꢀent who underwent transhiatal dysphagia and adequate weight regain. The paꢀent  
esophagectomy. Three paꢀents who underwent with megaesophagus and Chagas disease died due to  
cardioplasty developed significant gastroesophageal cardiomyopathy.  
■
FIGURE 3  
Discussion  
In the management of end-stage achalasia,  
the strategy should focus on preserving the organ.  
Recurrence of symptoms aꢂer surgical myotomy  
should be managed with peroral endoscopic myotomy  
(
POEM), redo Heller myotomy or on demand pneumaꢀc  
1-4  
dilaꢀons . Several procedures, such as cardioplasty,  
are available before performing esophageal resecꢀon.  
In our series, cardioplasty resulted a valid opꢀon to  
ameliorate dysphagia but is quesꢀoned due to the  
5
significant gastroesophageal reflux it may cause . In a  
recent publicaꢀon, Ithurralde et al. describe resecꢀon  
of the gastroesophageal juncꢀon and Roux-en-Y  
reconstrucꢀon; this opꢀon could result in saꢀsfactory  
outcomes and could be considered as an alternaꢀve  
6
treatment prior to esophagectomy . Despite all these  
conservaꢀve therapeuꢀc opꢀons, paꢀents should be  
closely monitored for early detecꢀon of the need for  
esophagectomy. Massivedilaꢀon oftheorgan(diameter  
>
6 cm) is a predictor of esophagectomy. Therefore,  
Surgical specimen of minimally invasive esophagectomy due to end-  
stage achalasia  
esophagectomy remains a potenꢀal indicaꢀon in  
paꢀents with recurrent achalasia and radiologic  
progression of the disease, especially in those who have  
■
FIGURE 4  
7,8  
failed all minimally invasive treatments . Cardioplasty  
was described many years ago and has evolved over  
ꢀ
me to the point where there are currently several  
publicaꢀons on laparoscopy, either using an endo  
stapler or hand suture. The procedure consists of a  
long esophageal myotomy in the full wall thickness. The  
incision is extended 5 to 6 cm proximally and 1 to 2 cm  
into the stomach to ensure complete dissecꢀon of the  
lower esophageal sphincter and destrucꢀon of the high-  
pressure zone. The length of the gastrostomy at the level  
of the fundus must be proporꢀonal to the length of the  
esophagotomy to prepare the anastomosis. Although  
esophagogastrostomy allows adequate esophageal  
emptying even in the presence of moꢀlity disorders, it  
should be considered a rescue procedure and paꢀents  
should receive proton pump inhibitors because of the  
gastroesophageal reflux it causes9 . The management  
of end-stage achalasia is complicated and represents  
a significant therapeuꢀc challenge due to the limited  
response to improve paꢀents’ symptoms and quality of  
life.  
,10  
Cardioplasty  
6
Rancés AC y cols. Abordaje mininvasivo de la acalasia en estadio final . Rev Argent Cir. 2025;117(1):1-6  
In conclusion, in the series presented cases based on mulꢀdisciplinary approach.  
a
here, minimally invasive cardioplasty was the most Further studies should be conducted  
used technique for the treatment of end-stage to determine which is the most appropriate  
achalasia, with a low percentage of complicaꢀons. option demonstrating long-term safety and  
Other techniques were also used for other selected efficacy.  
Referencias bibliográficas /References  
1
.
Devaney EJ, Lanneꢁoni MD, Orringer MB, Marshall B. Esopha-  
gectomy for achalasia: paꢀent selecꢀon and clinical experien-  
ce. Ann Thorac Surg. 2001;72(3):854-8. doi: 10.1016/s0003-  
Duque-Seguro C, Ferro D. Resecꢀon of the Gastroesophageal  
Juncꢀon and Roux-en-Y Reconstrucꢀon as a New Alternaꢀve for  
the Treatment of Recurrent Achalasia: Outcomes in a Short Series  
of Paꢀents. J Laparoendosc Adv Surg Tech A. 2020;30(2):121-6.  
doi: 10.1089/lap.2019.0300.  
4
975(01)02890-9.  
2
3
.
.
Glatz SM, Richardson JD. Esophagectomy for end stage achalasia.  
J Gastrointest Surg. 2007;11(9):1134-7. doi: 10.1007/s11605-007-  
7. Zaninoꢁo G, Benneꢁ C, Boeckxstaens G, Costanꢀni M, Ferguson  
MK, Pandolfino JE, et al. The 2018 ISDE achalasia guidelines. Dis  
Esophagus. 2018;31(9). doi: 10.1093/dote/doy071.  
0
226-8. Epub 2007 Jul 11.  
Griffiths EA, Deviꢁ PG, Jamieson GG, Myers JC, Thompson SK.  
Laparoscopic stapled cardioplasty for end-stage achalasia. J Gas-  
trointest Surg. 2013;17(5):997-1001. doi: 10.1007/s11605-012-  
8. Salvador R, Nezi G, Foraꢃni F, Riccio F, Viꢁori A, Provenzano L,  
et al. Laparoscopic Heller-Dor is an effecꢀve long-term treatment  
for end-stage achalasia. Surg Endosc. 2023;37(3):1742-8. doi:  
10.1007/s00464-022-09696-8.  
2
111-3.  
4
.
Menezes MA, Andolfi C, Herbella FA, Paꢃ MG. High-resoluꢀon  
manometry findings in paꢀents with achalasia and massive  
dilated megaesophagus. Dis Esophagus. 2017;30(5):1-4. doi:  
9. Loviscek MF, Wright AS, Hinojosa MW, Petersen R, Pajitnov D,  
Oelschlager BK, Pellegrini CA. Recurrent dysphagia aꢂer Heller  
myotomy: is esophagectomy always the answer? J Am Coll Surg.  
2013;216(4):736-43; discussion 743-4. doi: 10.1016/j.jamcoll-  
surg.2012.12.008.  
1
0.1093/dote/dow008.  
5
.
Aquino JL, Said MM, Leandro-Merhi VA, Ramos JP, Ichinoche L,  
Guimarães DM. Esophagocardioplasty as surgical treatment  
in relapsed non advanced megaesophagus. Arq Bras Cir Dig.  
10. Senra F, Navaratne L, Acosta-Mérida A, Gould S, Marꢄnez-Isla A. La-  
paroscopic hand-sewn cardioplasty: an alternaꢀve procedure for  
end-stage achalasia. Langenbecks Arch Surg. 2021;406(5):1675-  
82. doi: 10.1007/s00423-021-02117-9.  
2
6
012;25(1):20-4. English, Portuguese. doi: 10.1590/s0102-  
7202012000100005.  
6
.
Ithurralde-Argerich J, Cuenca-Abente F, Faerberg A, Rosner L,